Recombinant multi-species ARHGAP44 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARHGAP44 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables phospholipid binding activity. Predicted to be involved in several processes, including modification of dendritic spine; negative regulation of Rac protein signal transduction; and regulation of plasma membrane bounded cell projection organization. Located in leading edge membrane. Implicated in acquired immunodeficiency syndrome and skin melanoma. Biomarker of hepatocellular carcinoma and lung carcinoma. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 6330543G20,ARHGAP44,Arhgap44,NPC-A-10,RGD1305664,RICH-2,RICH2,Rho GTPase-activating protein 44,Rho-type GTPase-activating protein RICH2,RhoGAP interacting with CIP4 homologs protein 2 (RICH-2),Rich2

Target products collectionGo to ARHGAP44 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13991-Ag-1/ GM-Tg-hg-IP13991-Ag-2 Human ARHGAP44 protein Human
GM-Tg-rg-IP13991-Ag-1/ GM-Tg-rg-IP13991-Ag-2 Rat ARHGAP44 protein Rat
GM-Tg-mg-IP13991-Ag-1/ GM-Tg-mg-IP13991-Ag-2 Mouse ARHGAP44 protein Mouse
GM-Tg-cynog-IP13991-Ag-1/ GM-Tg-cynog-IP13991-Ag-2 Cynomolgus/Rhesus macaque ARHGAP44 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13991-Ag-1/ GM-Tg-felg-IP13991-Ag-2 Feline ARHGAP44 protein Feline
GM-Tg-cang-IP13991-Ag-1/ GM-Tg-cang-IP13991-Ag-2 Canine ARHGAP44 protein Canine
GM-Tg-bovg-IP13991-Ag-1/ GM-Tg-bovg-IP13991-Ag-2 Bovine ARHGAP44 protein Bovine
GM-Tg-equg-IP13991-Ag-1/ GM-Tg-equg-IP13991-Ag-2 Equine ARHGAP44 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13991-Ag-1/ GM-Tg-hg-IP13991-Ag-2; GM-Tg-rg-IP13991-Ag-1/ GM-Tg-rg-IP13991-Ag-2;
GM-Tg-mg-IP13991-Ag-1/ GM-Tg-mg-IP13991-Ag-2; GM-Tg-cynog-IP13991-Ag-1/ GM-Tg-cynog-IP13991-Ag-2;
GM-Tg-felg-IP13991-Ag-1/ GM-Tg-felg-IP13991-Ag-2; GM-Tg-cang-IP13991-Ag-1/ GM-Tg-cang-IP13991-Ag-2;
GM-Tg-bovg-IP13991-Ag-1/ GM-Tg-bovg-IP13991-Ag-2; GM-Tg-equg-IP13991-Ag-1/ GM-Tg-equg-IP13991-Ag-2
Products Name ARHGAP44 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ARHGAP44
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARHGAP44 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.